Short Interest in Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Rises By 33.8%

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) was the target of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 38,000 shares, a growth of 33.8% from the January 31st total of 28,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Surgical Science Sweden AB (publ) Price Performance

Shares of OTCMKTS SUSRF traded down $0.86 during trading on Wednesday, hitting $14.39. 1,000 shares of the company traded hands, compared to its average volume of 2,240. The business’s fifty day moving average is $14.43 and its 200 day moving average is $12.97. Surgical Science Sweden AB has a fifty-two week low of $11.30 and a fifty-two week high of $15.25.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.